{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:32:21Z","timestamp":1760783541852},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1212\/wnl.43.2.387","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:06:54Z","timestamp":1336914414000},"page":"387-387","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Phosphoglycerate kinase deficiency"],"prefix":"10.1212","volume":"43","author":[{"given":"P.","family":"Tonin","sequence":"first","affiliation":[{"name":"H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Departments of Neurology (Drs. Tonin, Shanske, Tsujino, and DiMauro) and Pathology (Dr. Miranda), Columbia-Presbyterian Medical Center, New York, NY, and the University of Calgary (Drs. Brownell and Wyse), Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shanske","sequence":"additional","affiliation":[{"name":"H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Departments of Neurology (Drs. Tonin, Shanske, Tsujino, and DiMauro) and Pathology (Dr. Miranda), Columbia-Presbyterian Medical Center, New York, NY, and the University of Calgary (Drs. Brownell and Wyse), Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Miranda","sequence":"additional","affiliation":[{"name":"H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Departments of Neurology (Drs. Tonin, Shanske, Tsujino, and DiMauro) and Pathology (Dr. Miranda), Columbia-Presbyterian Medical Center, New York, NY, and the University of Calgary (Drs. Brownell and Wyse), Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K.","family":"Brownell","sequence":"additional","affiliation":[{"name":"H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Departments of Neurology (Drs. Tonin, Shanske, Tsujino, and DiMauro) and Pathology (Dr. Miranda), Columbia-Presbyterian Medical Center, New York, NY, and the University of Calgary (Drs. Brownell and Wyse), Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Wyse","sequence":"additional","affiliation":[{"name":"H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Departments of Neurology (Drs. Tonin, Shanske, Tsujino, and DiMauro) and Pathology (Dr. Miranda), Columbia-Presbyterian Medical Center, New York, NY, and the University of Calgary (Drs. Brownell and Wyse), Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tsujino","sequence":"additional","affiliation":[{"name":"H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Departments of Neurology (Drs. Tonin, Shanske, Tsujino, and DiMauro) and Pathology (Dr. Miranda), Columbia-Presbyterian Medical Center, New York, NY, and the University of Calgary (Drs. Brownell and Wyse), Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"DiMauro","sequence":"additional","affiliation":[{"name":"H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Departments of Neurology (Drs. Tonin, Shanske, Tsujino, and DiMauro) and Pathology (Dr. Miranda), Columbia-Presbyterian Medical Center, New York, NY, and the University of Calgary (Drs. Brownell and Wyse), Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.43.2.387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:57:54Z","timestamp":1711645074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.43.2.387"}},"subtitle":["Biochemical and molecular genetic studies in a new myopathic variant (PGK Alberta)"],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["10.1212\/WNL.43.2.387"],"URL":"https:\/\/doi.org\/10.1212\/wnl.43.2.387","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,2]]}}}